Publications
5539 Results
- Journal / Conference
- American Society of Prevention Oncology :#76
- Year
- 2000
- Research Committee(s)
- Cancer Control
- Study Number(s)
- SWOG-9217
Dietary supplement use in the prostate cancer prevention trial: implications for study findings
- Journal / Conference
- Journal of Clinical Oncology 18(12):2444-2458
- Year
- 2000
- Research Committee(s)
- Melanoma
- Study Number(s)
- SWOG-9111 (EST-1690)
High-and low-dose interferon alfa-2b in high-risk melanoma: first analysis of Intergroup trial E1690/S9111/C9190
- Journal / Conference
- Lung Cancer 29(Suppl.2):7(#16)
- Year
- 2000
- Research Committee(s)
- Lung
- Study Number(s)
- S9714
Phase II evaluation of paclitaxel by 96-hour infusion in stage IIIb and IV bronchioloalveolar carcinoma (BAC)
- Journal / Conference
- Chest 117:358-364
- Year
- 2000
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-8992 (RTOG-88-08) (ECOG-45-88)
Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group
- Journal / Conference
- New England Journal of Medicine 342(15):1069-1076
- Year
- 2000
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-9412
Conventiional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer
- Journal / Conference
- New England Journal of Medicine 343(24):1750-1757
- Year
- 2000
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-9108 (CALGB-9011)
Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia
- Journal / Conference
- Prostate Cancer and Prostatic Diseases 3:145-151
- Year
- 2000
- Research Committee(s)
- Prevention and Epidemiology
- Study Number(s)
- S0000
SELECT: The selenium and vitamin E cancer prevention trial rationale and design
- Journal / Conference
- Proc of the American Society of Clinical Oncology 19:86a(#328)
- Year
- 2000
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-9514 (EB193)
Fenretinide (FEN) vs placebo in postmenopausal breast cancer patients receiving adjuvant tamoxifen (TAM), an Eastern Cooperative Oncology Group Phase III Intergroup Trial (EB193, INT-0151)
- Journal / Conference
- Journal of Urology 164(4):1321-1322
- Year
- 2000
- Research Committee(s)
- Cancer Control
- Study Number(s)
- SWOG-9217
Letter to the Editor: RE: RE: Chemoprevention of urological cancer
- Journal / Conference
- Proc of the American Society of Clinical Oncology 19:239a(#925)
- Year
- 2000
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-8899 (INT-0089)